|[April 23, 2014]
FDA Clears Siemens SOMATOM Force CT System
MALVERN, Pa. --(Business Wire)--
Siemens (News - Alert) Healthcare has announced that the U.S. Food and Drug
Administration (FDA) has cleared the SOMATOM® Force computed
tomography (CT) system - the next generation in dual source CT. With two
sets of Siemens' most innovative X-ray tubes and detectors, the SOMATOM
Force extends advanced imaging to all patients, including some of the
most challenging: young children, patients with renal insufficiency, and
patients who are unable to hold their breath. The SOMATOM Force
overcomes imaging limitations, making low-dose CT available for an even
broader array of patients. With the unparalleled power reserves of its
revolutionary Vectron tube, the SOMATOM Force delivers routine adult
imaging with fast, low-dose protocols.
"The SOMATOM Force represents a dramatic leap forward in CT technology,
helping healthcare organizations improve diagnostic confidence with
access to an imaging tool that maximizes the patient experience for many
more people in their communities," said Murat Gungor, vice president, CT
and radiation oncology business management, Siemens Healthcare.
For years, CT imagers have been investigating the usage of different
energy levels (kilovoltage or "kV") to elicit an enhanced
contrast-to-noise ratio and lower patient radiation dose. Lowering kV
levels also can potentially increase enhancement of contrast medium, so
less contrast may be necessary. This practice had limitations because
earlier generations of CT scanners could not sufficiently power imaging
at very low kV levels except when imaging children or very small adults.
In early investigational research with the SOMATOM Force, radiologists
have observed low, previously unachievable kV imaging results that are
enabled by the Force's power reserves.�
"The massively enhanced tube power of the SOMATOM Force enables imaging
that can be acquired at very low kV settings - and thus at a lower level
of radiation dose - routinely in adult patients and even those of a
larger body type. In the past, these low kV settings would have resulted
in noisy, nondiagnostic studies," said Joseph Schoepf, MD, director of
CT research and development and professor of radiology and cardiology at
Medical University of South Carolina.
Due to its low kV imaging, the SOMATOM Force broadens CT's application
for patients with renal insufficiency. While necessary for conventional
CT imaging, iodine contrast medium ca place a burden on the kidneys,
especially for older patients or those with chronic kidney disease.
Previously, clinicians had two options: scan without contrast or avoid
scanning entirely. The SOMATOM Force extends CT's use for these
patients, especially in urgent situations when they can most benefit.
An author of numerous published studies on the benefits of low kV
imaging and an internationally recognized expert in neuroradiology,
Lawrence N. Tanenbaum, MD, FACR, noted, "The SOMATOM Force enables
routine 70 kV imaging - a technique poised to make a tremendous impact
in day-to-day scanning of adult and pediatric patients, with benefits
such as decreased radiation dose and impressive time-resolved imaging."
With the industry's fastest, most versatile scanning mode, the SOMATOM
Force enables the user to perform an entire adult chest, abdomen, and
pelvis study in only one second, so patients need not hold their breath.
For example, patients who present with shortness of breath and are
evaluated for pulmonary embolism can now be imaged with no breath hold,
thanks to the SOMATOM Force's Turbo Flash Mode. With no need for a
patient breath hold, the healthcare organization can make faster, more
confident decisions and can better deliver timely intervention. In
cardiac imaging, the SOMATOM Force can obtain an entire study within a
quarter of a heart beat at a native temporal resolution of 66 ms - the
speed required to freeze even the fastest-moving anatomy such as the
right coronary artery.
The SOMATOM Force also may enable low-dose imaging in lung and colon
exams.� Low-dose imaging is attributable to two spectral filters known
as Selective Photon Shields that optimize the X-ray spectrum to
significantly improve air/soft-tissue contrast. Patients who are
diagnosed with lung or colon cancer are likely to undergo additional
follow-up imaging studies that can now be delivered at a continually low
dose to enable more decisive treatment and post-therapy evaluations.
1 With the low kV/high mA capabilities of the VECTRON tube,
SOMATOM Force allows scanning with a very high tube current of up to
1300 mA at 70, 80 and 90 kV, such that a high tube output even for these
low kV settings can be achieved. Along with SOMATOM Force's unique Turbo
Flash Mode, this scan configuration is also available for conventional
spiral or sequential scanning.
2 The SOMATOM Force may
achieve the same contrast-to-noise level (in terms of image pixel noise)
in the image in reduced dose.
The statements by Siemens customers described herein are based on
results that were achieved in the customer's unique setting. Since there
is no "typical" hospital and many variables exist (e.g., hospital size,
case mix, level of IT adoption), there can be no guarantee that other
customers will achieve the same results.
For further information regarding Siemens CT, please see
Follow us on Twitter (News - Alert): www.twitter.com/siemenshealth
The Siemens Healthcare Sector is one of the world's largest
suppliers to the healthcare industry and a trendsetter in medical
imaging, laboratory diagnostics, medical information technology and
hearing aids. Siemens offers its customers products and solutions for
the entire range of patient care from a single source - from prevention
and early detection to diagnosis, and on to treatment and aftercare. By
optimizing clinical workflows for the most common diseases, Siemens also
makes healthcare faster, better and more cost-effective. Siemens
Healthcare employs some 52,000 employees worldwide and operates around
the world. In fiscal year 2013 (to September 30), the Sector posted
revenue of 13.6 billion euros and profit of 2.0 billion euros. For
further information please visit: www.siemens.com/healthcare.
[ InfoTech Spotlight's Homepage ]